🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparative Effects of Task-Oriented Training and Hand-Arm Bimanual Intensive in Post-Stroke Patients

RecruitingNAAges 45 Years - 70 YearsAllRiphah International University
NCT07724925 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Stroke is a rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than a vascular origin. Among various rehabilitation strategies, Task-oriented training of low to moderate intensity and Hand-Arm bimanual intensive therapy have shown their promising results in stroke rehabilitation. So, this study aims to determine the comparative effects of Task-oriented and Hand-Arm bimanual intensive therapy on Gross and Fine motor skills of Upper Limb and Activities of Daily Living in Post-Stroke Patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • Age 45-70 * Gender (both male and female) * Pre diagnosed First-time stroke patients (ischemic or hemorrhagic) * Time since stroke: ≥3 months * Mild to moderate upper limb impairment (ABILHAND Questionnaire: Less than 50% of items rated as "impossible.") * Moderate functional independence in basic activities (Barthel Index score ≥ 60) * Ability to follow commands (MMSE \> 24 or equivalent cognitive screening) Exclusion Criteria: * • Severe spasticity (Modified Ashworth Scale score ≥ 3) or contractures * Other neurological conditions (Alzheimer's disease, Parkinson and dementia) * Unstable medical conditions (diabetes and hypertension) that may interfere with participation * Participation in any other structured upper limb rehabilitation or experimental therapy within the past 3 months
💊

What it tests

  • Task-Oriented Training
  • Hand-Arm Bimanual Intensive Therapy
📍

Where

1 site
DHQ Hospital Nankana Sahib
Nankana Sahib, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy